Dosing and Administration

ERLEADA®: once-daily oral dosing1

dosing bracket

Tablets shown are not actual size.

The recommended dose of ERLEADA® is 240 mg (four 60 mg tablets) administered  orally once daily 1

Patients should also receive a GnRH analog concurrently or should have had a bilateral orchiectomy.1

 

Dosing Icon

No need for co-administration of a corticosteroid.1

Can be taken with or without food. Tablets should be swallowed whole.1

No initial dose adjustments for ERLEADA® are necessary for renal or hepatic impairment.*1

Dose Modifications

If a patient experiences a ≥Grade 3 toxicity or an intolerable side effect, hold dosing until symptoms improve to ≤Grade 1 or original grade, and then resume at the same dose or a reduced dose (180 mg or 120 mg), if warranted.1

*ERLEADA® has not been evaluated in patients with severe renal or hepatic impairment.

GnRH = gonadotropin-releasing hormone.

Reference

1. ERLEADA® [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.